CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Biom’up has developed HEMOSNOW, a fast-acting haemostatic powder that effectively stops bleeding during surgery. This innovative solution aims to reduce operation time and improve patient recovery by providing surgeons with a ready-to-use tool for managing excessive blood loss.
Excessive blood loss during surgery is a major concern - 42% of all patients who experience excessive blood loss during surgery die.
Excessive bleeding contributes to longer hospital stays and delayed post-operative recovery.
This incurs costs for both hospitals and patients with increased operating room time estimated to cost €1,542 - €2,554/hour while increased hospital stay is estimated at €1,038/day.
Conventional techniques used to control excessive bleeding such as electrocautery are not al…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
